kitio.aiAdded Nov 5, 2026
ArteraAI
PaidAI pathology tests that predict cancer outcomes and therapy benefit
What is ArteraAI?
Artera offers AI-based prognostic tests for prostate and breast cancer that analyze digital images of existing biopsy slides together with clinical data. Its prostate test received FDA De Novo authorization and helps clinicians decide which patients benefit from added hormone therapy.
The tests use image data from standard H&E slides, so no extra tissue is consumed, and results come back from the company's CLIA lab within one to two days of receiving the specimen. Versions exist for biopsy, post-prostatectomy and metastatic hormone-sensitive prostate cancer.
The prostate test is included in NCCN guidelines as a prognostic test and has shown consistent results across African American and other patients. Clinicians order through an online portal, and the test is reimbursed for Medicare patients and by many insurers.
Features
- Prostate cancer risk test
- Breast cancer test
- Uses existing H&E slides
- 1-2 day turnaround
- Online ordering portal
Tags
Releases
+ Submit new release- Listed
ArteraAI was added to the directory.
Organization
Artera
🇺🇸 United States
Listed by kitio.ai · unverified owner
Pricing
- Pricing model
- Paid
- Paid options from
- Not listed
Sponsored
Your AI tool here
A Featured launch puts your tool in this spot and on the home page for a week.
Top ArteraAI alternatives
View allLegal, finance & HR
AI agents that read full cancer patient charts for trials and visits
Legal, finance & HR
Digital pathology platform with AI for labs and drug developers
Legal, finance & HR
AI genomics and radiomics platform for cancer and rare disease labs
Legal, finance & HR
AI for cancer screening on mammograms and chest X-rays
If you liked ArteraAI
Ambient AI medical scribe with specialty-tuned clinical notes
PaidLegal, finance & HRMade in United States- Healz.aiNew
AI cancer case reviews with oncologist second opinions in one chat
PaidLegal, finance & HR - Belong.LifeNew
AI health mentors and patient communities for chronic disease
FreemiumLegal, finance & HR Microsoft's AI clinical assistant for dictation and ambient notes
PaidLegal, finance & HRMade in United StatesAI medical search engine that answers clinical questions with citations
FreeLegal, finance & HR2 views2 clicks to the websiteMade in United States
Pros and cons
Pros
- FDA De Novo authorization
- Listed in NCCN prostate guidelines
- No additional tissue needed
Cons
- Ordered by clinicians only
- Covers few cancer types so far
- Cost depends on insurance coverage
Prompts & results
No prompts yet. Add your own prompt and output to help others use this tool.
Share a prompt
Reviews
Q&A
What is ArteraAI?
Artera offers AI-based prognostic tests for prostate and breast cancer that analyze digital images of existing biopsy slides together with clinical data. Its prostate test received FDA De Novo authorization and helps clinicians decide which patients benefit from added hormone therapy.
How long does an ArteraAI test take?
Results can be shared within one to two days after the lab receives the patient's specimen.
How much does ArteraAI cost?
ArteraAI is paid.
Is there a free version of ArteraAI?
No. ArteraAI is a paid tool.
What are the main features of ArteraAI?
Prostate cancer risk test, Breast cancer test, Uses existing H&E slides, 1-2 day turnaround, Online ordering portal.
Who makes ArteraAI?
ArteraAI is made by Artera.
What are the best alternatives to ArteraAI?
Popular alternatives include Triomics, Proscia, SOPHiA GENETICS.